Chiltern Wins Award at the Inaugural US Pharma Awards Ceremony

May 4, 2010
Research and Development

Glenn Kerkhof, Chiltern CEO, congratulated Kim Todd, Chiltern’s Silver Medal Award Winner in the category of experienced Clinical Research Associate/Site …

EU votes for tighter internet drug regulations

May 4, 2010
Sales and Marketing EU, counterfeits, viagra

The European Parliament has voted to enact stronger legislation against poor quality medicines available on the internet. The move comes …

Staff cuts already planned, warns nurses’ leader

May 4, 2010
NHS trusts, election, general election, nurses

The leader of nurses in the UK has warned that NHS trusts around the country are already planning significant job …

Contract research news in brief

May 4, 2010
Research and Development Corealis, Norwich Pharma, PPD, PRA, biofocus

Our round-up of developments in the contract research sector includes a new $41m contract for BioFocus, new locations for PPD, …

Evotec wins grant to advance H3 receptor antagonist

May 4, 2010
Research and Development CNS, Evotec, MS

Evotec is to receive funding of up to 1.5 million euros from a German government fund to advance its H3 …

Enlacamacomonunca.com

Digital Pharma: Bayer expands InBed ED campaign

April 30, 2010
Medical Communications Bayer Schering Pharma, digital pharma, disease awareness campaigns, erectile dysfunction

Bayer Schering Pharma has launched a Spanish version of its InBed erectile dysfunction disease awareness campaign. Under the tagline ‘en la …

Colorcon buys French excipients specialist

April 30, 2010
Manufacturing and Production Colorcon, Ethypharm, NP Pharm, contract manufacturing, excipients

US-based Colorcon has acquired excipient specialist NP Pharm, a division of French drugmaker Ethypharm, in order to expand its product portfolio …

Shire revenue dips after generic Adderall hit

April 30, 2010
Sales and Marketing Adderall, Fabrazyme, Gaucher's, Shire

Shire’s first quarter revenues fell by 5% after its ADHD treatment Adderall XR succumbed to generic competition from Teva.  This …

FDA warns Teva over California plant

April 30, 2010
Manufacturing and Production Teva, manufacturing compliance

Teva has become the latest drugmaker to be rebuked by the FDA for not responding effectively enough to compliance problems …

Plavix boosts BMS first quarter figures

April 30, 2010
Sales and Marketing BMS, Plavix

Plavix has boosted Bristol-Myers Squibb’s performance in the first quarter of the year, with sales of the anti-clotting blockbuster up …

Frazier

Merck separates president role, appoints Kenneth Frazier

April 30, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Merck & Co, appointment, manufacturing and production, research and development, sales and marketing

Merck & Co has partially split the joint roles of chairman, chief executive and president currently held by Richard Clark, …

Victoza claims head-to-head victory over Januvia

April 29, 2010
Research and Development, Sales and Marketing Novo, Novo Nordisk, Victoza

Novo Nordisk says its diabetes treatment showed “significant” benefits over Merck’s rival Januvia in a head-to-head trial. Results published in …

Investors get green light to continue Merck lawsuit

April 29, 2010
Merck, Vioxx

Investors suing Merck over ‘omissions and misstatements’ relating to its arthritis pain drug Vioxx will be allowed to continue with …

CME Spotlight: De-coding the letter of the law

April 29, 2010
Medical Communications CME, CME Spotlight

Legal systems can raise interesting philosophical points sometimes.At the time of writing, the UK is in the throws of a …

Doctors.net.uk reports record year for online interaction with doctors

April 29, 2010
Medical Communications CME, doctors.net, social networking

Online doctors’ community Doctors.net.uk says it saw record levels of doctor engagement in 2009, with 25 million unique web sessions during …

US pharma execs join Algeta board

April 29, 2010
Research and Development Algeta, appointment, research and development

Oslo-based oncology company Algeta has added Judith Hemberger and Kapil Dhingra to its board of directors. Judith Hemberger has more …

RNA Interference using nanoparticles hits target in human patients

April 29, 2010
Research and Development SiRNA, nanoparticles, rnai

US researchers have shown that a targeted nanoparticle can penetrate cancer cells in order to deliver small interfering RNAs (siRNAs), …

Asia and emerging markets boost GSK results

April 28, 2010
Sales and Marketing GSK

Asia and emerging markets boost GlaxoSmithKline results GlaxoSmithKline has seen a jump in pharma sales due to major growth in …

Merck bounces back

April 28, 2010
Sales and Marketing Merck KGaA

Merck KgaA tripled its profit year-on-year in the first quarter of 2010, largely on the back of a better than …

Obituary – Tony Forbes-Leith

April 28, 2010
Business Services appointment, business services, rsa

RSA director Tony Forbes-Leith passed away last month after a long and serious illness. He officially joined the company in …

The Gateway to Local Adoption Series

Latest content